Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
raleigh-durham blog main
san francisco blog main
2
×
san francisco top stories
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
bernie sanders
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
congress
crisis
deals
detroit blog main
detroit top stories
drug prices
easl
fatty liver disease
fda
food and drug administration
givosiran
house of representatives
indiana blog main
indiana top stories
indivior
insulin
intercept pharmaceuticals
lawsuit
legal
liver
liver congress
What
disease
2
×
drug
therapy
2
×
advanced
alnylam’s
approval
bff
bio
building
conference
deal
deals
developer
devoted
easl
established
firm
form
gene
kicked
liver
lung
major
momentum
pah
race
rare
reaches
rivalry
roundup
seller
steadymed
therapeutics
treat
united
updates
world's
Language
Current search:
disease
×
" san francisco blog main "
×
therapy
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
